BiotechTubeBiotechTube
Home/Mirum Pharmaceuticals/Mike Grey
MG

Mike Grey

Chairman of the Board

Mirum Pharmaceuticals

Roles

Chairman of the BoardatMirum Pharmaceuticals
Executive Chair, Board of DirectorsatAltay Therapeutics

Therapeutic Areas

Rare Liver DiseasesCholestasisInborn Errors of Bile Acid MetabolismChronic Hepatitis Delta Virus (HDV)Genetic Neurology

Mirum Pharmaceuticals Pipeline

DrugIndicationPhase
LIVMARLI® (maralixibat)Cholestatic pruritus in Alagille syndrome (ALGS)Approved
BrelovitugChronic Hepatitis Delta Virus (HDV)Phase 3
VolixibatCholestatic Liver Diseases (e.g., Primary Sclerosing Cholangitis)Phase 2b/3
Investigational TherapiesCerebrotendinous Xanthomatosis (CTX)Not Specified

Leadership Team at Mirum Pharmaceuticals

CP
Chris Peetz
Chief Executive Officer
EB
Eric Bjerkholt
Chief Financial Officer
EC
Erin Campany
Chief People Officer
HJ
Hassan Javanbakht, Ph.D.
Chief Scientific Officer
JG
Jean-Luc Girardet, Ph.D.
Chief Technical Officer
VK
Vinita Kumar
Senior Vice President, Quality
LL
Lara Longpre
Chief Development Officer
JQ
Joanne Quan, M.D.
Chief Medical Officer
PR
Peter Radovich
President & Chief Operating Officer
DS
Doug Sheehy, JD
Chief Legal Officer
View full Mirum Pharmaceuticals profile